Hi there, My name is Ian Cook. I am a journalist with progressive MS from the UK who is writing a regular free ezine about progressive MS. Issue five (December 2015/ January 2016) is attached. I hope you find it interesting. In this issue is some little reported news about a trial into Tysabri for… Read more »
Posts Categorized: MS News
MS Society invests another £1.98 million in research
Source MS Society: Sixteen projects have made it through the rigorous review process to secure funding from the MS Society’s 2015 grant round. Of the 16 applications awarded, five were for care and services projects, focusing mainly on symptom management and best approaches to service provision. The other 11 were biomedical projects which focus on… Read more »
Multiple Sclerosis Symptoms Reduced with Experimental Cancer Drug
Source MD In mouse models of multiple sclerosis (MS), experimental cancer drugs have shown therapeutic promise, according to findings published in the journal Nature. Read on.
Tysabri unsuccessful in secondary progressive MS trial
Source MS Trust: Preliminary results announced in a press release (link is external) report that treatment with Tysabri did not slow down the gradual increase in disability experienced by people with secondary progressive MS. Read on.
Progressive MS receives latest funding boost
Source MS Society: Eleven projects have received funding in the next step to find the most promising collaborative progressive MS research projects in the world. The progressive MS Alliance is a growing global collaboration committed to speeding up the development of treatment for progressive MS. Read on.
Multiple sclerosis patient walks after taking HIV drugs
Source BBC: A woman with multiple sclerosis (MS) says her symptoms improved so dramatically she was able to walk again after being prescribed HIV drugs. Shana Pezaro, 36, from Hove, East Sussex, was given antiretroviral drugs after fearing she may have contracted HIV. Read on.
ECTRIMS 2015 round up
Source MS Trust ECTRIMS (European Committee for Treatment and Research In Multiple Sclerosis) hosts the world’s largest conference devoted to basic and clinical research in MS. This year’s meeting took place in Barcelona from 7-10 October and featured a wide range of presentations, posters and reports of new and on-going research. Read on.
Biogen says multiple sclerosis drug trial for Natalizumab was unsuccessful.
Source Market Watch Biogen Inc. said Wednesday that a late-stage trial of a drug to treat of secondary progressive multiple sclerosis was unsuccessful. The trial of Natalizumab found that the drug was “well-tolerated” by patients but did not meet its primary and secondary endpoints. “While we’re disappointed with these results, we believe this research will… Read more »
Study on Biotin for Secondary and Primary Progressive Forms of Multiple Sclerosis
Dr. Daniel Kantor talks about the MD1003 Trial analysis on Biotin for Secondary and Primary Progressive Multiple Sclerosis. Watch here.
Want to take part in a clinical trial?
Note: For people with relapsing remitting MS or Secondary progressive MS only. Want to take part in a clinical trial? In recognition of your time involved in this study you will receive £1,250 and all your travel needs will be organised by Trials4Us. BMSTC will also receive a donation. Trials4Us are carrying out an important clinical trial… Read more »
